Pharmaceutical Executive
Obtaining patient perspectives during open-label extension trials.
Ross Weaver
Advertisement
Articles by Ross Weaver
Pharmaceutical Executive
Getting patient insights before launch is more feasible than you might think.
Advertisement
Latest Updated Articles
The Feasibility of Patient Insights Before LaunchJuly 16th 2019
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5